ITGR
Integer Holdings Corporation
Healthcare · Medical Devices · NYQ
$91.98
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$3.0B
Total market value of the company
22.08
Premium valuation
13.07
Based on estimated future earnings — lower means cheaper
Rev Growth
+0.5%
Year-over-year revenue change
Profit Margin
7.6%
How much profit the company keeps from each dollar of revenue
8.6%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$97.00
+5% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 9 analysts covering this stock
About Integer Holdings Corporation

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

https://www.integer.net

Country: United States Employees: 11,000 Industry: Medical Devices
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

MARKUP
Price trending up with increasing momentum
-0.214
Returns do not compensate for the risk — negative edge
-0.0237
No positive edge detected — the data suggests staying out
-0.249
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-14.0%
Historical annualised return based on price data
-56.1%
Largest peak-to-trough decline — the worst it has been
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
10
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

0.66
Less volatile than the market — more defensive
52W High
$123.78
26% below the year high
52W Low
$62.00
48% above the year low
Avg Volume
648,718
Average daily shares traded — higher means easier to buy and sell
6.8
Days it would take all short sellers to cover — higher means more crowded
Short % Float
15.0%
Elevated short interest — bears are positioned against this
N/A
Annual dividend as a percentage of the share price
$4.03
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

81.41
Heavy leverage — higher financial risk if revenues decline
3.76
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
2.19
Like current ratio but excludes inventory — stricter test
Gross Margin
26.8%
Revenue left after cost of goods — higher means pricing power
Operating Margin
8.2%
Profit from core operations before interest and tax
$98M
Positive — the business generates more cash than it spends
Revenue (TTM)
$1.9B
Total revenue over the last 12 months
Net Income
$142M
Profitable — the bottom line is positive
Analyst Coverage
Analysts
9
Target High
$115.00
Target Median
$97.00
Target Low
$84.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.